GSK is harnessing the power of digital technologies such as AI, ML, and deep learning for drug discovery and development; to reduce the time and operational costs involved in the drug discovery development process; and to improve products quality and enhance customer experience
The report provides information and insights into GlaxoSmithKline’s tech activities, including -
- Insights of its digital transformation strategies.
- Overview of technology initiatives covering partnerships, product launches, and investments.
- Insights on each technology initiative including technology theme, objective, and benefits
- Details of estimated ICT budgets and major ICT contracts
- GlaxoSmithKline is tapping key disruptive technologies to strengthen its operational and service competences.
- Artificial intelligence, IoT, big data, blockchain, mobile health, robotics, and augmented reality are the key technologies under focus for the company.
Reasons To Buy
- Gain insights into GlaxoSmithKline’s tech operations.
- Gain insights into its tech strategies and innovation initiatives.
- Gain insights into its technology themes under focus.
- Gain insights into various product launches, partnerships, and investments strategies.